Invitation to the 36th annual EMHG-meeting
On behalf of the board of directors of the European Malignant Hyperthermia Group (EMHG) and the members of the local organizing committee, we are very pleased to welcome you to the 36th annual meeting of the European Malignant Hyperthermia Group which will take place in Antwerp, Belgium on June 1st and 2nd 2017.
Our congress motto this year is ‘Malignant Hyperthermia is but one of the RYR1 myopathies’ emphasizing (again) that - even though the main focus of the EMHG was and is peroperative anaesthesia-induced Malignant Hyperthermia – more and more evidence is emerging showing a wide clinical spectrum of RYR1related disorders: Malignant Hyperthermia, Chronic HyperCKemia, Exercise Induced Rhabdomyolysis, Exertional Myalgia, and a range of congenital myopathies such as Central Core Disease, Centronuclear Myopathy and Congenital Fibre Type Disproportion.
More often than before these patients too are referred to the MH-labs for diagnostic advice, requiring a multidisciplinary approach by anaesthesiologists, neurologists, geneticists and sport physicians. Two of the invited lectures given by eminent speakers specifically deal with the translational research in these domains.
The congress will be held on June 1st and 2nd at the heart of the University of Antwerp Stadscampus, the historic Hof van Liere Convention halls. For further information please visit:
and www.visitantwerpen.be (EN, FR, D,NL).
We will certainly try to continue the trend of successful past annual meetings and hope to further contribute to the spirit of friendship and collaboration as known since the first meetings of our group. Indeed the EMHG always stood for close collaboration, an increasingly important asset in facilitating an integrated approach to research in this domain.
Norgine has confirmed their sponsorship for the 36th annual EMHG meeting.
We look forward to welcoming you and spending a great time in Antwerp.
Luc Heytens Joris De Puydt Jonathan Baets